Syndopa CR 250 mg (Carbidopa /Levodopa) Ajanta Cabergoline tablets should be taken

Cabergoline tablets should be taken orally with water

Patients should report any unusual bruising

room-temperature setting below 30°C to protect the integrity of the active formulation

The formulation complies with international pharmacopeial standards and is intended for use under medical supervision

This lowers heart rate

Syndopa CR 250 mg (Carbidopa /Levodopa) Ajanta Cabergoline tablets should be takenProduct Overview Syndopa CR 250 mg is a sustainedrelease formulation that combines two essential antiParkinson agents, carbidopa and levodopa, in a single tablet. Manufactured by Sun Pharmaceutical Industries Ltd, this medication is specifically indicated for the symptomatic treatment of Parkinsons disease, a progressive neurodegenerative disorder that affects motor function. The sustainedrelease technology allows for a more consistent plasma